S100A4 and glioblastoma: Among the most significantly deregulated genes, we observed downregulation of S100A4, a recently identified regulator of immunosuppressive T cells and pro-tumorigenic macrophages in GBM cells, and an important target for immunotherapy (Fig. 6a)13.